1402586-75-7

Upstream product

• 1402586-74-6 ethyl 2-(3-fluoro-4-((N-methylmethylsulfonamido )methyl)phenyl)propanoate 
• 112734-22-2 4-bromo-2-fluorobenzylamine 
• 1402586-73-5 ethyl 2-(3-fluoro-4-(methylsulfonamidomethyl)phenyl)propanoate 
• 1402586-72-4 N-[(4-bromo-2-fluorophenyl)methyl]methanesulfonamide 

Downstream Products

• 1428790-03-7 2-(3-fluoro-4-((N-methylmethylsulfonamido) methyl)phenyl)-N-((2-(4-methylpiperidin-1-yl)-6-(trifluoromethyl)pyridin-3-yl)methyl)propanamide 
• 1435483-90-1 N-[[2-(3-chlorophenyl)-5-(trifluoromethyl)-2H-pyrazol-3-yl]methyl]-2-[3-fluoro-4-[(methyl-methylsulfonylamino)methyl]phenyl]propionamide 

Relevant academic research and scientific papers

Amine Substituted Methanesulfonamide Derivatives as Vanilloid Receptor Ligands

The invention relates to amine substituted methanesulfonamide derivatives as vanilloid receptor ligands, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.

AMINE SUBSTITUTED METHANESULFONAMIDE DERIVATIVES AS VANILLOID RECEPTOR LIGANDS

The invention relates to amine substituted methanesulfonamide derivatives of formula (I) as vanilloid receptor ligands, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.

SUBSTITUTED PYRAZOLYL-BASED CARBOXAMIDE AND UREA DERIVATIVES BEARING A PHENYL MOIETY SUBSTITUTED WITH AN N-CONTAINING GROUP AS VANILLOID RECEPTOR LIGANDS

The invention relates to substituted pyrazolyl-based carboxamide and urea derivatives of formula (R) bearing a phenyl moiety substituted with an N-containing group as vanilloid receptor ligands, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.